Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatotoxicity after long-term methotrexate therapy.

F S Reynolds, W M Lee

    Southern Medical Journal
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study.

    ESMO open·2026
    Same author

    Multimodal decoding of human liver regeneration.

    Nature·2024
    Same author

    Odderon Exchange from Elastic Scattering Differences between pp and pp[over ¯] Data at 1.96 TeV and from pp Forward Scattering Measurements.

    Physical review letters·2021
    Same author

    Measurement of the Effective Weak Mixing Angle in pp[over ¯]→Z/γ^{*}→ℓ^{+}ℓ^{-} Events.

    Physical review letters·2018
    Same author

    Combined Forward-Backward Asymmetry Measurements in Top-Antitop Quark Production at the Tevatron.

    Physical review letters·2018
    Same author

    Constraints on Oscillation Parameters from ν_{e} Appearance and ν_{μ} Disappearance in NOvA.

    Physical review letters·2017

    For patients on long-term methotrexate therapy, repeat liver biopsies are recommended after five years of treatment. Early biopsies may not be necessary, as significant liver changes correlate with treatment duration, not other patient factors.

    Area of Science:

    • Hepatology
    • Pharmacology
    • Medical Diagnostics

    Background:

    • Long-term methotrexate (MTX) therapy is common for various conditions.
    • The necessity of routine liver biopsies for monitoring MTX-induced hepatotoxicity requires reassessment.
    • Previous guidelines on liver biopsy frequency for MTX users are debated.

    Purpose of the Study:

    • To evaluate the need for repeat liver biopsies in patients undergoing long-term methotrexate treatment.
    • To identify factors associated with methotrexate-induced liver injury.
    • To determine optimal surveillance strategies for MTX hepatotoxicity.

    Main Methods:

    • Retrospective review of 15 liver biopsies from 14 patients on long-term methotrexate therapy (1979-1984).
    • Analysis of liver histology, correlating findings with patient demographics, biochemical markers, and treatment duration.

    Related Experiment Videos

  • Assessment of the severity of liver changes (fibrosis, cirrhosis) and impact on treatment continuation.

    • Main Results:

    • Seven patients (47%) exhibited significant changes in liver histology.
    • Four biopsies (27%) revealed grade III or IV changes (fibrosis or cirrhosis), leading to treatment discontinuation.
    • No correlation was found between histologic changes and biochemical abnormalities, obesity, anemia, or age at MTX initiation.
    • Treatment duration exceeding five years was the most significant factor associated with severe liver toxicity.

    Conclusions:

    • Surveillance liver biopsies are advisable for patients treated with methotrexate for five years or longer.
    • Liver biopsies within the first five years of methotrexate therapy may not be essential.
    • Further validation in larger patient cohorts is recommended to confirm these findings.